Login / Signup

Sacubitril/valsartan attenuates atrial conduction disturbance and electrophysiological heterogeneity with ameliorating fibrosis in mice.

Satoshi IwamiyaKensuke IharaTetsushi FurukawaTetsuo Sasano
Published in: Frontiers in cardiovascular medicine (2024)
Our results demonstrated that SacVal can improve the conduction disturbance and heterogeneity through the attenuation of fibrosis in murine atria and reduce the susceptibility of AF in heart failure with pressure overload, which might be attributed to the enhanced function of CNP.
Keyphrases
  • atrial fibrillation
  • heart failure
  • single cell
  • liver fibrosis
  • high fat diet induced
  • metabolic syndrome
  • adipose tissue
  • cardiac resynchronization therapy
  • skeletal muscle